You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Integrin beta 3 antibody [CRC54] (ab34409)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab34409? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab34409 has been referenced in 3 publications.

  1. Alghisi GC et al. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One 4:e4449 (2009). ICC/IF; Human. PubMed: 19212436
  2. Reynolds AR et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med 15:392-400 (2009). Flow Cyt; Human. PubMed: 19305413
  3. Khaspekova SG et al. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa] Biokhimiia 61:412-28 (1996). PubMed: 8724599

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"